Kyle Carnase is an accomplished finance professional with extensive experience in Financial Planning and Analysis (FP&A) across several prominent companies in the biotechnology and healthcare sectors. Currently serving as Associate Director of FP&A at Geron Corporation since April 2025, Kyle previously held similar roles at Editas Medicine and AGTC, where expertise in financial reporting and budget forecasting was developed. Prior positions include Sr. Financial Analyst roles at Alnylam Pharmaceuticals, focusing on research and development, along with financial analyst positions at Mass General Hospital and Collard Advisory Group. Kyle began a finance career with internships at Collard Advisory Group and Capitol 401K, while holding a degree from Bentley University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices